Value of Life Year and Cost-Effectiveness Thresholds: The Case of Poland

Bertram, M. Y., Lauer, J. A., De Joncheere, K., Edejer, T., Hutubessy, R., Kieny, M.-P., & Hill, S. R. (2016). Cost–effectiveness thresholds: Pros and cons. Bulletin of the World Health Organization, 94(12), 925–930. https://doi.org/10.2471/blt.15.164418 BertramM. Y. LauerJ. A. De JoncheereK. EdejerT. HutubessyR. KienyM.-P. HillS. R. 2016 Cost–effectiveness thresholds: Pros and cons Bulletin of the World Health Organization 94 12 925 930 https://doi.org/10.2471/blt.15.164418 10.2471/BLT.15.164418 Search in Google Scholar

Carson, R. (2012). Contingent valuation: A comprehensive bibliography and history. Edward Elgar Publishing. CarsonR. 2012 Contingent valuation: A comprehensive bibliography and history Edward Elgar Publishing Search in Google Scholar

Culyer, A. J. (2016). Cost-effectiveness thresholds in health care: A bookshelf guide to their meaning and use. Health Economics, Policy and Law, 11(4), 415–432. https://doi.org/10.1017/s1744133116000049 CulyerA. J. 2016 Cost-effectiveness thresholds in health care: A bookshelf guide to their meaning and use Health Economics, Policy and Law 11 4 415 432 https://doi.org/10.1017/s1744133116000049 10.1017/S1744133116000049 Search in Google Scholar

Desaigues, B., Ami, D., Bartczak, A., Braun-Kohlová, M., Chilton, S., Czajkowski, M., et al. (2011). Economic valuation of air pollution mortality: A 9-country contingent valuation survey of value of a life year (VOLY). Ecological Indicators, 11(3), 902–910. https://doi.org/10.1016/j.ecolind.2010.12.006 DesaiguesB. AmiD. BartczakA. Braun-KohlováM. ChiltonS. CzajkowskiM. 2011 Economic valuation of air pollution mortality: A 9-country contingent valuation survey of value of a life year (VOLY) Ecological Indicators 11 3 902 910 https://doi.org/10.1016/j.ecolind.2010.12.006 10.1016/j.ecolind.2010.12.006 Search in Google Scholar

Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2015). Methods for the economic evaluation of health care programmes. Oxford university press. DrummondM. F. SculpherM. J. ClaxtonK. StoddartG. L. TorranceG. W. 2015 Methods for the economic evaluation of health care programmes Oxford university press Search in Google Scholar

Friedman, H. S. (2021). Ultimate price: The value we place on life. University of California Press. FriedmanH. S. 2021 Ultimate price: The value we place on life University of California Press Search in Google Scholar

Gallacher, K., Morrison, D., Jani, B., Macdonald, S., May, C. R., Montori, V. M., et al. (2013). Uncovering treatment burden as a key concept for stroke care: A systematic review of qualitative research. PLoS Med, 10(6), e1001473 https://doi.org/10.1371/journal.pmed.1001473. GallacherK. MorrisonD. JaniB. MacdonaldS. MayC. R. MontoriV. M. 2013 Uncovering treatment burden as a key concept for stroke care: A systematic review of qualitative research PLoS Med 10 6 e1001473 https://doi.org/10.1371/journal.pmed.1001473. 10.1371/journal.pmed.1001473 Search in Google Scholar

Giergiczny, M. (2006). Wycena wartości statystycznego życia ludzkiego przy wykorzystaniu metody wyborów z eksperymentami. Ekonomia i Środowisko, 2, 42–56. GiergicznyM. 2006 Wycena wartości statystycznego życia ludzkiego przy wykorzystaniu metody wyborów z eksperymentami Ekonomia i Środowisko 2 42 56 Search in Google Scholar

Hanemann, W. M. (1984). Welfare evaluation in contingent valuation experiments with discrete responses. American Journal of Agricultural Economics, 66(3), 332–341. https://doi.org/10.2307/1240800 HanemannW. M. 1984 Welfare evaluation in contingent valuation experiments with discrete responses American Journal of Agricultural Economics 66 3 332 341 https://doi.org/10.2307/1240800 10.2307/1240800 Search in Google Scholar

Hutubessy, R., Chisholm, D., & Edejer, T. T. T. (2003). Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Effectiveness and Resource Allocation, 1(1), 1–13. HutubessyR. ChisholmD. EdejerT. T. T. 2003 Generalized cost-effectiveness analysis for national-level priority-setting in the health sector Cost Effectiveness and Resource Allocation 1 1 1 13 10.1186/1478-7547-1-1 Search in Google Scholar

Jakubiak-Lasocka, J., & Jakubczyk, M. (2014). Cost-effectiveness versus cost-utility analyses: What are the motives behind using each and how do their results differ?—A Polish example. Value in Health Regional Issues, 4, 66–74. https://doi.org/10.1016/j.vhri.2014.06.008 Jakubiak-LasockaJ. JakubczykM. 2014 Cost-effectiveness versus cost-utility analyses: What are the motives behind using each and how do their results differ?—A Polish example Value in Health Regional Issues 4 66 74 https://doi.org/10.1016/j.vhri.2014.06.008 10.1016/j.vhri.2014.06.008 Search in Google Scholar

Johannesson, M., & Johansson, P. O. (1996). To be, or not to be, that is the question: An empirical study of the WTP for an increased life expectancy at an advanced age. Journal of Risk and Uncertainty, 13(2), 163–174. https://doi.org/10.1007/bf00057866 JohannessonM. JohanssonP. O. 1996 To be, or not to be, that is the question: An empirical study of the WTP for an increased life expectancy at an advanced age Journal of Risk and Uncertainty 13 2 163 174 https://doi.org/10.1007/bf00057866 10.1007/BF00057866 Search in Google Scholar

Markiewicz, O. (2008). Analiza opłacalności programów ochrony zdrowia na podstawie wyceny statystycznego życia i wyceny dodatkowego roku przeżycia w Polsce. Praca doktorska przygotowana pod kierunkiem prof. dr hab.Tomasza Żylicza, Uniwersytet Warszawski, Wydział Nauk Ekonomicznych, Warszawa. MarkiewiczO. 2008 Analiza opłacalności programów ochrony zdrowia na podstawie wyceny statystycznego życia i wyceny dodatkowego roku przeżycia w Polsce Praca doktorska przygotowana pod kierunkiem prof. dr hab.Tomasza Żylicza, Uniwersytet Warszawski, Wydział Nauk Ekonomicznych Warszawa Search in Google Scholar

McFadden, D. (1974). Conditional logit analysis of qualitative choice behavior. Frontiers in Econometrics, New York Academic Press, 105–142. McFaddenD. 1974 Conditional logit analysis of qualitative choice behavior Frontiers in Econometrics New York Academic Press 105 142 Search in Google Scholar

McCabe, C., Claxton, K., & Culyer, A. J. (2008). The NICE cost-effectiveness threshold. Pharmacoeconomics, 26(9), 733–744. McCabeC. ClaxtonK. CulyerA. J. 2008 The NICE cost-effectiveness threshold Pharmacoeconomics 26 9 733 744 10.2165/00019053-200826090-00004 Search in Google Scholar

Meyerhoff, J., & Liebe, U. (2006). Protest beliefs in contingent valuation: Explaining their motivation. Ecological Economics, 57(4), 583–594. https://doi.org/10.1016/j.ecolecon.2005.04.021 MeyerhoffJ. LiebeU. 2006 Protest beliefs in contingent valuation: Explaining their motivation Ecological Economics 57 4 583 594 https://doi.org/10.1016/j.ecolecon.2005.04.021 10.1016/j.ecolecon.2005.04.021 Search in Google Scholar

O’Mahony, J. F., & Coughlan, D. (2016). The Irish cost-effectiveness threshold: Does it support rational rationing or might it lead to unintended harm to Ireland’s health system?. Pharmacoeconomics, 34(1), 5–11. https://doi.org/10.1007/s40273-015-0336-1 O’MahonyJ. F. CoughlanD. 2016 The Irish cost-effectiveness threshold: Does it support rational rationing or might it lead to unintended harm to Ireland’s health system? Pharmacoeconomics 34 1 5 11 https://doi.org/10.1007/s40273-015-0336-1 10.1007/s40273-015-0336-1 Search in Google Scholar

Orlewska, E., & Mierzejewski, P. (2000). Polskie wytyczne przeprowadzania badań farmakoekonomicznych (projekt). Farmakoekonomika, 4(supl 1), 2–11. OrlewskaE. MierzejewskiP. 2000 Polskie wytyczne przeprowadzania badań farmakoekonomicznych (projekt) Farmakoekonomika 4 supl 1 2 11 Search in Google Scholar

Orlewska, E., & Mierzejewski, P. (2003). Project of polish guidelines for conducting pharmacoeconomic evaluations in comparison to international health economic guidelines. The European Journal of Health Economics, formerly: HEPAC, 4(4), 296–303. https://doi.org/10.1007/s10198-003-0185-2 OrlewskaE. MierzejewskiP. 2003 Project of polish guidelines for conducting pharmacoeconomic evaluations in comparison to international health economic guidelines The European Journal of Health Economics, formerly: HEPAC 4 4 296 303 https://doi.org/10.1007/s10198-003-0185-2 10.1007/s10198-003-0185-2 Search in Google Scholar

Schulman, K. A. (1991). Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) Infection. Annals of Internal Medicine, 114(9), 798–802. https://doi.org/10.7326/0003-4819-114-9-798 SchulmanK. A. 1991 Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) Infection Annals of Internal Medicine 114 9 798 802 https://doi.org/10.7326/0003-4819-114-9-798 10.7326/0003-4819-114-9-798 Search in Google Scholar

Thokala, P., Ochalek, J., Leech, A. A., & Tong, T. (2018). Cost-Effectiveness Thresholds: the Past, the Present and the Future. PharmacoEconomics, 36(5), 509–522. https://doi.org/10.1007/s40273-017-0606-1 ThokalaP. OchalekJ. LeechA. A. TongT. 2018 Cost-Effectiveness Thresholds: the Past, the Present and the Future PharmacoEconomics 36 5 509 522 https://doi.org/10.1007/s40273-017-0606-1 10.1007/s40273-017-0606-1 Search in Google Scholar

Torrance, G. W., & Feeny, D. (1989). Utilities and Quality-Adjusted Life Years. International Journal of Technology Assessment in Health Care, 5(4), 559–575. https://doi.org/10.1017/s0266462300008461 TorranceG. W. FeenyD. 1989 Utilities and Quality-Adjusted Life Years International Journal of Technology Assessment in Health Care 5 4 559 575 https://doi.org/10.1017/s0266462300008461 10.1017/S0266462300008461 Search in Google Scholar

Torrance, G. W., & Zipursky, A. (1984). Cost-Effectiveness of Antepartum Prevention of Rh Immunization. Clinics in Perinatology, 11(2), 267–281. https://doi.org/10.1016/s0095-5108(18)30920-5 TorranceG. W. ZipurskyA. 1984 Cost-Effectiveness of Antepartum Prevention of Rh Immunization Clinics in Perinatology 11 2 267 281 https://doi.org/10.1016/s0095-5108(18)30920-5 10.1016/S0095-5108(18)30920-5 Search in Google Scholar

Vallejo-Torres, L., García-Lorenzo, B., Castilla, I., Valcárcel-Nazco, C., García-Pérez, L., Linertová, R., et al. (2016). On the estimation of the cost-effectiveness threshold: Why, what, how?. Value in Health, 19(5), 558–566. https://doi.org/10.1016/j.jval.2016.02.020 Vallejo-TorresL. García-LorenzoB. CastillaI. Valcárcel-NazcoC. García-PérezL. LinertováR. 2016 On the estimation of the cost-effectiveness threshold: Why, what, how? Value in Health 19 5 558 566 https://doi.org/10.1016/j.jval.2016.02.020 10.1016/j.jval.2016.02.020 Search in Google Scholar

Williams, A. (1985). Economics of coronary artery bypass grafting. British Medical Journal (Clin Res Ed), 291(6491), 326–329. https://doi.org/10.1136/bmj.291.6491.326 291(6491), 326–329. WilliamsA. 1985 Economics of coronary artery bypass grafting British Medical Journal (Clin Res Ed) 291 6491 326 329 https://doi.org/10.1136/bmj.291.6491.326 291(6491), 326–329. 10.1136/bmj.291.6491.326 Search in Google Scholar

Woods, B., Revill, P., Sculpher, M., & Claxton, K. (2016). Country-level cost-effectiveness thresholds: Initial estimates and the need for further research. Value in Health, 19(8), 929–935. https://doi.org/10.1016/j.jval.2016.02.017 WoodsB. RevillP. SculpherM. ClaxtonK. 2016 Country-level cost-effectiveness thresholds: Initial estimates and the need for further research Value in Health 19 8 929 935 https://doi.org/10.1016/j.jval.2016.02.017 10.1016/j.jval.2016.02.017 Search in Google Scholar

Żylicz, T. (2014). Cena przyrody. Wydawnictwo Ekonomia i Środowisko. ŻyliczT. 2014 Cena przyrody Wydawnictwo Ekonomia i Środowisko Search in Google Scholar